Saakshi Medtech & Panels Management Change
Saakshi Medtech and Panels Limited issued a revised disclosure regarding the appointment of Mr. Nandkumar Vasant Dhekne as Independent Director and Mr. Ravi Madhav Vartak as Whole-time Director.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements with these filters
Saakshi Medtech and Panels Limited issued a revised disclosure regarding the appointment of Mr. Nandkumar Vasant Dhekne as Independent Director and Mr. Ravi Madhav Vartak as Whole-time Director.
Saakshi Medtech and Panels Limited received NSE's in-principle approval to list 2,010,259 equity shares of ₹10 each issued via preferential allotment.
Saakshi Medtech and Panels Limited has scheduled its 17th Annual General Meeting for September 30, 2026. Shareholders will consider financial statements and director appointments.
Saakshi Medtech and Panels Limited announced the re-appointment of Mr. Aniket Latkar as Chairman and Managing Director for a five-year term, effective June 8, 2026.
Saakshi Medtech and Panels Limited approved the preferential allotment of 2,010,259 equity shares at Rs. 207 per share, aggregating to Rs. 41.61 Crore.
Saakshi Medtech received in-principle approval from NSE for a preferential issue of 20,22,940 equity shares. The shares are priced at Rs. 207 each via share swap.
Saakshi Medtech received an updated valuation report for its proposed preferential issue. The report supports the fair value of assets being acquired without changing issue terms.